Gene Therapy
Gene therapy delivers a working copy of a gene, or a correction to a faulty one, usually once and for life. Manufacturing the delivery vector is often harder than designing the therapy.
131 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 101 |
VA
VR Adviser
New York
| $179M | -$9.61M | 7 | 11.43% | Reduced |
|
| 102 |
OrbiMed
New York
| $179M | +$9.61M | 9 | 3.54% | Increased |
|
| 103 |
Legal & General Group
London,
United Kingdom
| $178M | +$10.7M | 54 | 0.05% | Increased |
|
| 104 |
Two Sigma Advisers
New York
| $177M | -$3.33M | 36 | 0.39% | Reduced |
|
| 105 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
| $173M | +$59.9M | 9 | 0.17% | Increased |
|
| 106 |
Eventide Asset Management
Boston,
Massachusetts
| $172M | +$4.26M | 8 | 2.95% | Increased |
|
| 107 |
SB
Samsara BioCapital
Palo Alto,
California
| $171M | -$766K | 6 | 35.79% | Reduced |
|
| 108 |
Bellevue Group
Kuesnacht,
Switzerland
| $167M | +$4.16M | 12 | 2.71% | Increased |
|
| 109 |
UBS O'Connor
Chicago,
Illinois
| $163M | +$60.2M | 10 | 4.58% | Increased |
|
| 110 |
BVF Inc
San Francisco,
California
| $161M | -$8.35M | 5 | 4.52% | Reduced |
|
| 111 |
ACM
Aisling Capital Management
New York
| $158M | $0 | 3 | 68.58% | Maintained |
|
| 112 |
Chevy Chase Trust
Bethesda,
Maryland
| $153M | +$26M | 4 | 0.49% | Increased |
|
| 113 |
Bank of Montreal
Toronto,
Ontario, Canada
| $153M | +$76.1M | 16 | 0.04% | Increased |
|
| 114 |
Capital Research Global Investors
Los Angeles,
California
| $152M | -$602 | 2 | 0.03% | Reduced |
|
| 115 |
Cowen and Company
New York
| $152M | +$2.24M | 5 | 4.17% | Increased |
|
| 116 |
VOYA Investment Management
Atlanta,
Georgia
| $151M | -$5.38M | 40 | 0.15% | Reduced |
|
| 117 |
Swiss National Bank
Zurich,
Switzerland
| $148M | +$3.06M | 23 | 0.1% | Increased |
|
| 118 |
Citigroup
New York
| $145M | -$188M | 65 | 0.09% | Reduced |
|
| 119 |
B
Braidwell
Stamford,
Connecticut
| $145M | +$2.19M | 6 | 4.56% | Increased |
|
| 120 |
New York State Common Retirement Fund
Albany,
New York
| $144M | -$12.7M | 61 | 0.19% | Reduced |
|
| 121 |
Scharf Investments
Los Gatos,
California
| $144M | -$1.35M | 1 | 4.1% | Reduced |
|
| 122 |
RhumbLine Advisers
Boston,
Massachusetts
| $143M | +$35.5M | 70 | 0.13% | Increased |
|
| 123 |
Mondrian Investment Partners
London,
United Kingdom
| $142M | -$79.6M | 1 | 2.18% | Reduced |
|
| 124 |
Laurion Capital Management
New York
| $142M | -$28.8M | 7 | 1.68% | Reduced |
|
| 125 |
Lord, Abbett & Co
Jersey City,
New Jersey
| $141M | -$121M | 3 | 0.46% | Reduced |
|